Elanco Animal Health
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.2% | -0.8% | +6.2% | +0.1% | +6.6% | +45.5% | -7.4% | +0.1% | +0.5% | +6.2% | |
| – | -6.9% | +8.6% | +3.3% | -5.7% | +21.3% | +32.6% | -9.2% | +1.6% | +2.1% | +5.3% | |
| – | +10.0% | -12.0% | +10.4% | +8.1% | -11.0% | +66.5% | -5.1% | -1.6% | -1.5% | +7.4% | |
| – | -8.7% | -5.3% | -2.0% | +9.5% | +21.1% | +12.8% | -13.0% | +1.9% | +5.2% | +7.0% | |
| – | -14.3% | -0.6% | -5.7% | +3.4% | +31.1% | +16.0% | -7.9% | +0.8% | +0.5% | +32.7% | |
| – | -13.0% | -1.8% | -4.8% | +4.9% | +28.5% | +33.9% | -10.5% | +1.6% | +2.9% | +8.4% | |
| – | +5,144.4% | -49.7% | +120.4% | +17.9% | -120.8% | – | +26.3% | -15.1% | -23.0% | +0.4% | |
| – | – | – | – | +166.6% | +97.7% | +69.2% | -3.0% | +8.2% | +22.4% | -35.1% | |
| – | – | – | – | -31.5% | -959.3% | – | – | – | – | -145.9% | |
| – | – | +206.3% | -64.7% | -62.7% | -1,186.4% | – | – | +500.0% | +316.7% | -94.7% | |
| – | – | – | – | -21.5% | -924.9% | – | – | – | – | -168.6% | |
| – | – | -63.0% | +412.5% | +7.3% | -99.8% | +45,344.4% | +111.7% | -125.9% | – | -54.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.